Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisis
The Washington state attorney general has announced a $149.5 million settlement agreement with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role in the opioid addiction crisis.
J&J's Janssen settles with WVa for $99M in opioid lawsuit
West Virginia will receive $99 million in a settlement finalized with Johnson & Johnsonโs subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.
Millions of dollars headed to Bexar County to help opioid addicts get more resources
Bexar County residents who have an opioid addiction will soon have more resources available to help them after the county approved a roughly $12 million portion of a settlement between the State of Texas and Johnson & Johnson worth more than $290 million.
How much Texas gets from multistate, $26 billion opioid settlement hinges on how many local governments sign on
The state and its political subdivisions could get up to $1.5 billion from the settlement. But some local governments are considering pursuing their own lawsuits against drug makers and distributors.
Strong Q2 from J&J as pandemic-hit sales, profit recover
Johnson & Johnsonโs second-quarter profit soared 73%, thanks to strong sales growth, particularly in its medical device and diagnostics segment, as hospitals and the health care industry as a whole continue recovering from the coronavirus pandemic.
EXPLAINER: $26B opioid settlement big step, but not the end
A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant โ but it is far from tying a neat bow on the tangle of still-unresolved lawsuits surrounding the epidemic.
US opioid lawsuits on verge of settlements with 4 companies
The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion deal to settle lawsuits brought by state and local governments across the country over the toll of prescription opioids, lawyers suing on behalf of local governments said.